Activation of the K-Ras oncogene has been implicated in more than 90% of pancreatic carcinogenesis, and K-Ras mutation represents one of the earliest genetic alterations in pancreatic cancer development [14]. Here, KRAS is linked to familial pancreatic carcinoma.